jRCTs051240302招募中不适用
Study to Investigate the GLP-1 Secretion-Promoting Effect of Foods Containing Allulose
未提供0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 20
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Crossover Assignment
- 主要目的
- Prevention Purpose
- 盲法
- Double Blind
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- All
入选标准
- •Healthy adult
排除标准
- •Individuals with impaired glucose tolerance (as it may affect test results related to blood glucose, etc.).
- •Individuals with a history of using incretin-related drugs (as it may affect test results related to blood glucose, etc.).
- •Individuals with a BMI below 18.5 or above 30.
- •Individuals who are pregnant or plan to give birth during the study period.
- •Other individuals deemed unsuitable by the principal investigator.
结局指标
主要结局
-
Change in blood GLP-1 concentration
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Investigation of the effect of endogenous GLP-1 on cardiac function in chronic heart failurePatients with chronic heart failureJPRN-UMIN000009361Gifu University100
已完成
3 期
Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 DiabetesHealthyType 2 DiabetesNCT04466618Adrian Vella23
招募中
不适用
Observation of using GLP-1 receptor agonist for wellness of brain activity in type 2 diabetes patients with mild cognitive impairmentJPRN-UMIN000030840Ogawa Red Cross Hospital50
已完成
1 期
The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)Diabetes Mellitus, Type 2NCT01449019Ludwig-Maximilians - University of Munich24
已完成
不适用
GLP-1 administration test for assessing the glucose metabolism and predictive efficacy of the incretin based treatmentType 2 diabetes mellitusJPRN-UMIN000010067Miyazaki university50